The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.
Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens.
Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.
The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.